pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Jul 13·1 min read
save

Cayman court orders Apple Tree Partners to lose control of its venture fund

Jul 13, 2026·read at Endpoints ↗Neutral

A Cayman Islands court ruled that Apple Tree Partners' general partner must give up control of its venture fund.

The decision follows a dispute with the fund's main limited partner, and the judge in the Grand Court issued the ruling on Friday.

The loss adds to the challenges facing the embattled firm, which has been dealing with legal and operational issues.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Cayman court says Apple Tree general partner should lose control of venture fund”

read at Endpoints ↗
84 words · retrieved Jul 13
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 34m agoMerck's top dealmaker signals more M&A as Keytruda's patent cliff nearsEndpoints
  • 3h agoNovartis' drug delivery deal with Alteogen; More worker cuts at CellaresEndpoints
  • 4h agoPfizer shares ADC rights with Medicus; RevMed updates lung cancer dataEndpoints
  • 4h agoAbbVie claims Phase 3 win for multiple myeloma drug etentamigEndpoints
  • 5h agoHealth tech investors are looking at bigger betsEndpoints